Sarcopenia in type 2 diabetes mellitus (review and own observations)

Abstract

Background. A review of the literature on sarcopenia syndrome presents its definition, classifications and etiological factors. The main attention is paid to the correlation between sarcopenia and carbohydrate metabolism, in particular, between glycogen content and insulin sensitivity. The publications dealing with the mechanisms of influence of physical activity (short-term and long-term) on carbohydrate metabolism are analyzed. It is emphasized that today there is an evidence base on the role of skeletal muscles in maintaining glucose homeostasis, which justifies the importance of physical activity for the prevention of type 2 diabetes mellitus (DM) and monitoring such patients. Our observations were carried out to compare the frequency of the increase in the percentage of fat tissue (FT) and the reduction in muscle tissue in patients with different body mass index (BMI) and the effects of type 2 DM on these indicators. Materials and methods. A bioimpedance study was performed in 114 patients with type 2 DM aged 52.3 ± 1.7 years and 110 persons of the same age without type 2 DM (control group). Results. In all those surveyed with overweight and obesity, the age norms of percentage of FT were increased, regardless of the presence or absence of type 2 DM. At normal body weight in the control group in almost half of the examinees (52.0 %), there was an increase in the specific weight of the FT, and in the presence of type 2 DM, this index was significantly higher (94.1 %). This suggests that exceeding the age norms for the percentage of FT in persons with normal body weight can be regarded as a risk factor for type 2 DM. Conclusions. The incidence of a decrease in the specific weight of FT in the control group was 8.0 % in normal body weight, 20.0 % — in overweight and 80.0 % — in obesity that indicates the significance of the problem of sarcopenia, primarily in persons with obesity. Against the background of type 2 DM, these rates were significantly higher with normal body weight (41.2 %, p < 0.02), 2 times higher — with overweight, but lower (unreliably) — with obesity (61.1 %). The problem of sarcopenia in DM type 2 is relevant for patients with various BMI.

Authors and Affiliations

O. A. Goncharova

Keywords

Related Articles

Photoperiodism and Function of the Reproductive System in Mammals and Human

It is found that the change of day length affects the timing of puberty, depending on the action of light status in the prenatal or postnatal ontogenesis.

The practical importance of depression diagnosis in type 2 diabetes mellitus patients

Background. Nowadays diabetes mellitus (DM) and depression are widespread and socially significant diseases. A lot of studies and works are dedicated to this diseases, although modern view on the etiology of DM and depre...

New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus

This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin del...

Pathogenetic Features of Gastroduodenal Peptic Ulcer Associated with Hypertension and Diabetes Mellitus Type 2

The development and course of gastroduodenal peptic ulcer are associated with the strains of H.pylori (сagA+ vacA+, сagA+ vacА–, сagA– vacA+, сagA– vacA–) that was found in patients in the presence of comorbidity and in...

The Dynamics of Iodine Deficiency Disorders in the Republic of Karakalpakstan Based on the Epidemiological Studies of 1998, 2004 and 2014

The article summarizes the results of monitoring for iodine deficiency disorders in Karakalpakstan from 1998 to 2014. In accordance with the WHO recommendations, there were assessed the following indicators: the prevalen...

Download PDF file
  • EP ID EP176323
  • DOI 10.22141/2224-0721.13.2.2017.100611
  • Views 57
  • Downloads 0

How To Cite

O. A. Goncharova (2017). Sarcopenia in type 2 diabetes mellitus (review and own observations). Міжнародний ендокринологічний журнал, 13(2), 186-194. https://europub.co.uk/articles/-A-176323